[1]
Eichenfield, L., Gold, L.S., Silverberg, N., Raoof, T., Hooper, D., Moore, A., Zaiac, M., Sullivan, T., Kircik, L., Lain, E., Dhawan, S., Jones, T., Weiss, J., Draelos, Z., Ellman, H., deVries, T., Jankicevic, J. and Stuart, I. 2019. Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S2. DOI:https://doi.org/10.25251/skin.3.supp.2.